Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform
about
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future researchDopamine agonists for the treatment of cocaine dependenceDopamine agonists for the treatment of cocaine dependenceEfficacy of Psychostimulant Drugs for Cocaine DependencePsychostimulant treatment of cocaine dependenceImaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityMonetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers.Treatment retention among African-Americans in the Dane County Drug Treatment CourtAnti-relapse medications: preclinical models for drug addiction treatment.The effects of polyunsaturated fatty acids in alcohol dependence treatment--a double-blind, placebo-controlled pilot study.High-dose naltrexone therapy for cocaine-alcohol dependenceA placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine.Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trialContingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentEnduring effects of tacrine on cocaine-reinforced behavior: Analysis by conditioned-place preference, temporal separation from drug reward, and reinstatement.Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trialIncreased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent SubjectsInfluence of acute bupropion pre-treatment on the effects of intranasal cocaineCardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation.Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers.Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence.Drugs currently in Phase II clinical trials for cocaine addiction.New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.Psychostimulant drugs for cocaine dependence.The influence of baseline marijuana use on treatment of cocaine dependence: application of an informative-priors bayesian approach.Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.Cocaine sensitization increases subthreshold activity in dopamine neurons from the ventral tegmental area.Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex.Comparatively preserved impulse control in late-onset opiate users.
P2860
Q22241485-22B6E699-63E1-4D44-AB0D-50FC6870981EQ24187799-C3D0F689-FBEF-4C98-9C39-88F654D0AD64Q24234240-ACC85B9F-64B4-40F3-AAA0-7CAB87A20BD6Q24239994-B9608637-A37B-4D37-9604-AA3515BD94EEQ28267550-6E92C263-3D51-47D4-93CD-B2EE1154AD1BQ30422045-93988D3D-3217-4C9E-8BCB-CA695CE37E08Q33695272-1F3D220F-B0EA-41A7-9193-ABBB59BD2827Q33901896-E2A4EB37-8F6B-4E64-AA56-D3EC4B66BDACQ33927470-BCC1E777-01D2-4226-B261-2981EE352E40Q33970586-5F97AC8B-697D-494B-AF14-6B688B56A0BFQ34010096-CDDACAF6-483C-43BF-8853-59F09C43C7B9Q34091611-9DCAA462-6860-4226-A7CB-B2EA9C9A394BQ34533895-90FFE492-371A-401A-A54B-6380518DEEF1Q35160234-0D3F160D-FA30-4059-8046-929A58D2B9E2Q35188662-4DA175B7-2C49-4457-897C-DBDE0532EB2BQ35576598-BDE18FEA-9AF2-47B3-94C6-E1118ECF36C2Q35607225-2170383B-416E-44B2-888F-1C6C2EF0503DQ35733058-E84D3345-5BC9-495E-A7AE-42DD95B1EF19Q35875805-1E0D0E2E-AF16-48FD-AE03-28ECA68F1CA1Q35990520-76C03686-DCDA-46CF-92FB-8862E3B4EAEDQ36076392-BC1F6799-E8F0-4C23-B448-7DA9C3B4A650Q36165527-118B4400-DE92-4A6A-9F4E-766F4F15365AQ36199252-5C1F1FE4-1860-40E2-8C26-4021A99C390DQ36249079-86A7B4AF-4C78-41DD-AF4D-5A69355AE31FQ36693056-1149F737-096E-48D4-9036-B0581ABA2FF0Q36857705-0A4213E2-3FCF-4138-AA41-0642904D7E43Q37343634-0537A227-C84B-432F-A85C-C470B51E2C6EQ37621846-177A2AF1-3457-4B12-A8AD-6B99ECDA15C0Q38145448-E3A8B585-584F-457A-A388-AD4AE912A30EQ38207705-8A278163-ECDE-4A81-B286-D90DABE8C391Q38843745-777E13EB-B90D-4800-939C-A714642625FEQ38964799-6D124B85-4BD3-4755-A8DE-7951D4889D1CQ39527439-7D64668F-6560-4001-8D8C-3925BC86DA36Q47157142-B56D00AA-D3B6-4147-8651-C60F61B17D0FQ47366972-14B9C6D2-06F7-4764-BD22-F40D5E204FEEQ47828012-046043E6-AFB0-48C5-9596-E74A4C5743C1Q48249065-6A34F52C-DF73-49CB-BFBB-3D036F2A98C7Q50702310-A067D925-C98A-490A-9181-36F283FE4085
P2860
Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@ast
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@en
type
label
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@ast
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@en
prefLabel
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@ast
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@en
P2093
P2860
P1476
Levodopa pharmacotherapy for c ...... al behavioral therapy platform
@en
P2093
Angela L Stotts
Charles Green
F Gerard Moeller
John Grabowski
Marc E Mooney
P2860
P304
P356
10.1016/J.DRUGALCDEP.2007.11.004
P577
2007-12-27T00:00:00Z